Navigation

CG79 Rheumatoid arthritis: quick reference guide

The web version of the quick reference guide was updated in April 2009 to remove text that stated an incorrect dose of etoricoxib for rheumatoid arthritis patients. The quick reference guide now reads: ‘If offering a non-steroidal anti-inflammatory drug (NSAID) or a cyclo-oxygenase 2 (COX-2) inhibitor, offer a standard drug as a first choice.’

In August 2010, NICE published TA195 Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor. This replaces TA126 Rheumatoid arthritis (refractory) - rituximab and TA141 Rheumatoid arthritis (refractory) - abatacept, which are referred to in CG79 Rheumatoid arthritis in section 2 of the NICE guideline and in the footnote of page 6 of the quick reference guide. Please see TA195 Rheumatoid arthritis - drugs for treatment after failure of a TNF inhibitor for the updated recommendations.

This page was last updated: 23 January 2011

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.